Werewolf Therapeutics, Inc.·4

Jan 6, 5:44 PM ET

Isaacs Randi 4

4 · Werewolf Therapeutics, Inc. · Filed Jan 6, 2025

Insider Transaction Report

Form 4
Period: 2025-01-02
Isaacs Randi
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-02+187,500187,500 total
    Exercise: $1.56Exp: 2034-12-31Common Stock (187,500 underlying)
  • Award

    Stock Option (right to buy)

    2025-01-02+68,15168,151 total
    Exercise: $1.56From: 2027-01-02Exp: 2034-12-31Common Stock (68,151 underlying)
Footnotes (1)
  • [F1]The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4